WAGNER ESTER-C 1000MG + BIOFLAVONOIDS Austrália - inglês - Department of Health (Therapeutic Goods Administration)

wagner ester-c 1000mg + bioflavonoids

vitaco health australia pty ltd - calcium ascorbate dihydrate,calcium l-threonate,calcium carbonate,citrus bioflavonoids extract -

NUTRA-LIFE ESTER-C + BIOFLAVONOIDS Austrália - inglês - Department of Health (Therapeutic Goods Administration)

nutra-life ester-c + bioflavonoids

vitaco health australia pty ltd - calcium ascorbate dihydrate, quantity: 976.5 mg (equivalent: ascorbic acid, qty 806.78 mg); calcium carbonate, quantity: 11.2 mg; citrus bioflavonoids extract, quantity: 100 mg (equivalent: hesperidin, qty 35 mg); calcium l-threonate, quantity: 12.3 mg (equivalent: calcium, qty 1.623 mg) - tablet, film coated - excipient ingredients: crospovidone; copovidone; magnesium stearate; silicon dioxide; microcrystalline cellulose; polysorbate 80; purified talc; macrogol 4000; polyvinyl alcohol - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support collagen formation ; maintain/support general health and wellbeing ; maintain/support connective tissue health ; aid/assist/helps connective tissue production/formation ; maintain/support blood capillary health ; maintain/support blood vessel health ; maintain/support immune system health ; maintain/support healthy immune system function ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; aid/assist/helps synthesis of neurotransmitters ; maintain/support nervous system health ; maintain/support nervous system function ; decrease/reduce/relieve common cold duration ; decrease/reduce/relieve the severity of common cold symptoms ; maintain/support skin health ; maintain/support wound healing

NUTRA-LIFE ESTER-C HIGH STRENGTH + BIOFLAVONOIDS Austrália - inglês - Department of Health (Therapeutic Goods Administration)

nutra-life ester-c high strength + bioflavonoids

vitaco health australia pty ltd - calcium ascorbate dihydrate, quantity: 1.465 g (equivalent: ascorbic acid, qty 1.15 g); calcium carbonate, quantity: 16.8 mg; citrus bioflavonoids extract, quantity: 100 mg (equivalent: hesperidin, qty 35 mg); calcium l-threonate, quantity: 18.45 mg (equivalent: calcium, qty 2.435 mg) - tablet, film coated - excipient ingredients: crospovidone; microcrystalline cellulose; silicon dioxide; magnesium stearate; copovidone; polysorbate 80; purified talc; macrogol 4000; polyvinyl alcohol; flavour - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support collagen formation ; maintain/support general health and wellbeing ; maintain/support connective tissue health ; aid/assist/helps connective tissue production/formation ; maintain/support blood capillary health ; maintain/support blood vessel health ; maintain/support immune system health ; maintain/support healthy immune system function ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; aid/assist/helps synthesis of neurotransmitters ; maintain/support nervous system health ; maintain/support nervous system function ; decrease/reduce/relieve common cold duration ; decrease/reduce/relieve the severity of common cold symptoms ; maintain/support skin health ; maintain/support wound healing

CALCIUM - D - SOURCE Israel - inglês - Ministry of Health

calcium - d - source

gsk consumer healthcare, israel ltd - calcium carbonate; calcium lactate gluconate; colecalciferol - tablets effervescent - calcium lactate gluconate 1358 mg; calcium carbonate 1050 mg; colecalciferol 4 mg - calcium lactate gluconate - calcium lactate gluconate - calcium and vitamin d supplement. calcium helps in the maintenance of bones and teeth. vitamin d helps in the absorption and use of calcium.

CALCIUM SYRUP Austrália - inglês - APVMA (Australian Pesticides and Veterinary Medicines Authority)

calcium syrup

elanco australasia pty ltd - calcium lactobionate; calcium gluconate - oral solution/suspension - calcium lactobionate mineral-calcium active 24.25 g/100ml; calcium gluconate mineral-calcium-salt active 10.39 g/100ml - nutrition & metabolism - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - calcium supplement

CALCIUM GLUCONATE - FRESENIUS Israel - inglês - Ministry of Health

calcium gluconate - fresenius

medic trim healthcare ltd - calcium gluconate - solution for injection - calcium gluconate 902.5 mg / 10 ml - calcium gluconate - calcium gluconate - all conditions where injectable calcium supplement is indicated.

CALCIUM SOURCE 500 MG Israel - inglês - Ministry of Health

calcium source 500 mg

gsk consumer healthcare, israel ltd - calcium (as carbonate); calcium (as lactate gluconate) - tablets effervescent - calcium (as lactate gluconate) 149.7 mg; calcium (as carbonate) 350.3 mg - calcium gluconate - calcium gluconate - oral calcium therapy.

CALCIUM ACETATE capsule Estados Unidos - inglês - NLM (National Library of Medicine)

calcium acetate capsule

hikma pharmaceuticals usa inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c: calcium acetate capsules contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown.

CALCIUM ACETATE tablet Estados Unidos - inglês - NLM (National Library of Medicine)

calcium acetate tablet

camber pharmaceuticals, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate tablets contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown. a c

CALCIUM ACETATE capsule Estados Unidos - inglês - NLM (National Library of Medicine)

calcium acetate capsule

remedyrepack inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate capsule is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and d